Back to results
US 2007/0185018 A1Published application
Use of secretin in treatments of disorders associated with the amygdala
AssigneeThe McLean Hospital Corporation
InventorsDeborah Yurgelun-Todd, Perry Renshaw
Life of this patent
Estimating the term…
Abstract
In general, the present invention provides methods for treating disorders associated with the amygdala. The methods of treatment are based on the administration of a therapeutically effective amount of secretin to an individual suffering from a disorder associated with the amygdala, e.g., bipolar disorder or a substance use disorder.
Claims7
A method for treating an individual suffering from a disorder associated with the amygdala, said method comprising administering a therapeutically effective amount of secretin to said individual.
Dependencies are inferred from the claim text.